NCT03805620

Brief Summary

The present study aims to investigate the effects of combined physical-cognitive training on cognitive function as well as peripheral BDNF level and mitochondrial function of individuals with MCI. It is hypothesized that: 1) the combined physical-cognitive training program will be superior to the physical and cognitive training program alone; and 2) the degree of cognitive improvement will be positively correlated with the improvement of plasma BDNF and mitochondrial function.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
128

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Mar 2019

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 7, 2019

Completed
8 days until next milestone

First Posted

Study publicly available on registry

January 15, 2019

Completed
2 months until next milestone

Study Start

First participant enrolled

March 18, 2019

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 15, 2021

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 28, 2021

Completed
Last Updated

May 29, 2024

Status Verified

May 1, 2024

Enrollment Period

1.8 years

First QC Date

January 7, 2019

Last Update Submit

May 25, 2024

Conditions

Keywords

mild cognitive impairmentcombined physical-cognitive trainingBDNFmitochondrial functioncognitive function

Outcome Measures

Primary Outcomes (4)

  • change from baseline Alzheimer's Disease Assessment- cognitive subscale at 3 months

    Alzheimer's Disease Assessment-cognitive subscale will be assessed at baseline and 3 months. The total scores range from 0-70, with higher scores (≥ 18) indicating greater cognitive impairment.

    3 months

  • change from baseline Rey auditory verbal learning score at 3 months

    Memory will be assessed using Rey auditory verbal learning test.

    3 months

  • change from baseline Trail Making B-A score at 3 months

    Executive function will be assessed using Trail Making Test part B-A.

    3 months

  • change from baseline brain-derived neurotrophic factor level at 3 months

    Level of plasma brain-derived neurotrophic factor (BDNF) will be determined.

    3 months

Secondary Outcomes (5)

  • change from baseline Digit Span score at 3 months

    3 months

  • change from baseline stepping response time at 3 months

    3 months

  • change from baseline time to complete Timed Up and Go at 3 months

    3 months

  • change from baseline physiological profile assessment score at 3 months

    3 months

  • change from baseline cellular oxidative stress level at 3 months

    3 months

Study Arms (4)

Phys Group

ACTIVE COMPARATOR

physical training group

Other: Physical training

Cog Group

ACTIVE COMPARATOR

cognitive training group

Other: Cognitive training

Phys-Cog Group

EXPERIMENTAL

combined physical-cognitive training group

Other: Combined physical-cognitive training

Con Group

NO INTERVENTION

educational control group

Interventions

combined physical-cognitive training

Phys-Cog Group

Multi-component physical exercise

Phys Group

cognitive training

Cog Group

Eligibility Criteria

Age60 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • meet criteria for mNCD (mild neurocognitive disorders), previously known as MCI, based on the recent DSM-V (Diagnostic Statistical Manual-V) criteria
  • comprehend instructions and willing to participate
  • able to comply with the study schedule and procedures
  • not taking any medications for their cognition and not planning to start medications during the study trial

You may not qualify if:

  • presence of medical conditions that would be unsafe to exercise
  • diagnosed with other neurological conditions (e.g. Parkinson's disease, Stroke, Multiple Sclerosis, AD) that affect cognition and mobility
  • presence of depressive symptoms
  • presence of acute or/and chronic disease that could not be controlled (e.g. Arthritis, Asthma, Hypertension, Diabetes mellitus, Coronary artery disease)
  • exercise regularly (at least 30 min/day, 3 days/week)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of Associated Medical Sciences, Chiang Mai University

Chiang Mai, 50200, Thailand

Location

MeSH Terms

Conditions

Cognitive Dysfunction

Interventions

Physical Conditioning, HumanCognitive Training

Condition Hierarchy (Ancestors)

Cognition DisordersNeurocognitive DisordersMental Disorders

Intervention Hierarchy (Ancestors)

ExerciseMotor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological PhenomenaNeurological RehabilitationRehabilitationAftercareContinuity of Patient CarePatient CareTherapeuticsHealth ServicesHealth Care Facilities Workforce and Services

Study Officials

  • Somporn Sungkarat, PhD

    Chiang Mai University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
OTHER
Intervention Model
FACTORIAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

January 7, 2019

First Posted

January 15, 2019

Study Start

March 18, 2019

Primary Completion

January 15, 2021

Study Completion

June 28, 2021

Last Updated

May 29, 2024

Record last verified: 2024-05

Data Sharing

IPD Sharing
Will not share

Locations